Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15086)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 28, 2019 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Akateh C, Black SM, Conteh L, Miller ED, Noonan A, Elliott E, Pawlik TM, Tsung A, Cloyd JM. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma. World J Gastroenterol 2019; 25(28): 3704-3721 [PMID: 31391767 DOI: 10.3748/wjg.v25.i28.3704] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i28/3704.htm |
| Number | Citing Articles |
| 1 |
Shadi Chamseddine, Michael LaPelusa, Ahmed Omar Kaseb. Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma—A Narrative Review. Cancers 2023; 15(13): 3508 doi: 10.3390/cancers15133508
|
| 2 |
Maowen Yu, Chaozhu Zhang, Hongbo Tang, Chaohui Xiao, Hangjun Che. Correlation between Serum Oxidative Stress Level and Serum Uric Acid and Prognosis in Patients with Hepatitis B-Related Liver Cancer before Operation. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/1964866
|
| 3 |
Qi Pan, Zigong Shao, Yijie Zhang, Hao Liu. MicroRNA-1178-3p suppresses the growth of hepatocellular carcinoma by regulating transducin (beta)-like 1 X-linked receptor 1. Human Cell 2021; 34(5): 1466 doi: 10.1007/s13577-021-00565-5
|
| 4 |
Yuna Kim, Hyeok Jun Yun, Kyung Hwa Choi, Chan Wung Kim, Jae Ha Lee, Raymond Weicker, Seok-Mo Kim, Ki Cheong Park. Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer. International Journal of Molecular Sciences 2023; 24(22): 16413 doi: 10.3390/ijms242216413
|
| 5 |
Hao Wu, Jinrui Zhang, Yi Bai, Sai Zhang, Zhixin Zhang, Wen Tong, Pinsheng Han, Bing Fu, Yamin Zhang, Zhongyang Shen. DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinoma. Aging 2021; 13(19): 23020 doi: 10.18632/aging.203593
|
| 6 |
Masahiko Kinoshita, Daiju Ueda, Toshimasa Matsumoto, Hiroji Shinkawa, Akira Yamamoto, Masatsugu Shiba, Takuma Okada, Naoki Tani, Shogo Tanaka, Kenjiro Kimura, Go Ohira, Kohei Nishio, Jun Tauchi, Shoji Kubo, Takeaki Ishizawa. Deep Learning Model Based on Contrast-Enhanced Computed Tomography Imaging to Predict Postoperative Early Recurrence after the Curative Resection of a Solitary Hepatocellular Carcinoma. Cancers 2023; 15(7): 2140 doi: 10.3390/cancers15072140
|
| 7 |
Daniel W. Nelson, Jean-Nicolas Vauthey. Optimizing Treatment Strategies with Preoperative Assessment for Microvascular Invasion in Hepatocellular Carcinoma. Annals of Surgical Oncology 2023; 30(2): 660 doi: 10.1245/s10434-022-12746-z
|
| 8 |
Ahmed N. Elfadaly, Diamantis I. Tsilimigras, J. Madison Hyer, Alessandro Paro, Fabio Bagante, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Impact of Tumor Burden Score on Conditional Survival after Curative‐Intent Resection for Hepatocellular Carcinoma: A Multi‐Institutional Analysis. World Journal of Surgery 2021; 45(11): 3438 doi: 10.1007/s00268-021-06265-3
|
| 9 |
Taicheng Lu, Liying Wei, Xiaoqing Huang, Yin Li, Guo Li, Qixiao Qin, Meishi Pan, Bingling Tang, Xin Pan, Mei Wei, Zhenzhen Nong, Fayan Meng, Xuehua Li. A potentially valuable nano graphene oxide/USPIO tumor diagnosis and treatment system. Materials Science and Engineering: C 2021; 128: 112293 doi: 10.1016/j.msec.2021.112293
|
| 10 |
Riccardo Nevola, Rachele Ruocco, Livio Criscuolo, Angela Villani, Maria Alfano, Domenico Beccia, Simona Imbriani, Ernesto Claar, Domenico Cozzolino, Ferdinando Carlo Sasso, Aldo Marrone, Luigi Elio Adinolfi, Luca Rinaldi. Predictors of early and late hepatocellular carcinoma recurrence. World Journal of Gastroenterology 2023; 29(8): 1243-1260 doi: 10.3748/wjg.v29.i8.1243
|
| 11 |
Shashank Kumar, Abhay Kumar Pandey. Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma. Current Oncology 2023; 30(2): 1363 doi: 10.3390/curroncol30020105
|
| 12 |
Jungmin Kim, Hang-Seok Chang, Hyeok Jun Yun, Ho-Jin Chang, Ki Cheong Park. New Small-Molecule SERCA Inhibitors Enhance Treatment Efficacy in Lenvatinib-Resistant Papillary Thyroid Cancer. International Journal of Molecular Sciences 2024; 25(19): 10646 doi: 10.3390/ijms251910646
|
| 13 |
Francesco Izzo, Meredith C. Mason, Eric J. Silberfein, Nader N. Massarweh, Cary Hsu, Hop S. Tran Cao, Raffaele Palaia, Mauro Piccirillo, Andrea Belli, Renato Patrone, Roberta Fusco, Vincenza Granata, Steven A. Curley. Long-Term Survival and Curative-Intent Treatment in Hepatitis B or C Virus-Associated Hepatocellular Carcinoma Patients Diagnosed during Screening. Biology 2022; 11(11): 1597 doi: 10.3390/biology11111597
|
| 14 |
Emidio Scarpellini, Giuseppe Guido Maria Scarlata, Valeria Santori, Marialaura Scarcella, Nazarii Kobyliak, Ludovico Abenavoli. Gut Microbiota, Deranged Immunity, and Hepatocellular Carcinoma. Biomedicines 2024; 12(8): 1797 doi: 10.3390/biomedicines12081797
|
| 15 |
Tomohiro Ishinuki, Shigenori Ota, Kohei Harada, Hiroomi Tatsumi, Keisuke Harada, Koji Miyanishi, Minoru Nagayama, Ichiro Takemasa, Toshio Ohyanagi, Thomas T Hui, Toru Mizuguchi. Health-related quality of life in patients that have undergone liver resection: A systematic review and meta-analysis. World Journal of Meta-Analysis 2021; 9(1): 88-100 doi: 10.13105/wjma.v9.i1.88
|
| 16 |
Tao Bai, Zhi-hong Tang, Xiao-bo Wang, Jie Chen, Jia-zhou Ye, Shao-long Lu, Meng Wei, Fei-xiang Wu, Le-qun Li. Radiotherapy is superior to transarterial chemoembolization as adjuvant therapy after narrow-margin hepatectomy in patients with hepatocellular carcinoma: A single-center prospective randomized study. Langenbeck's Archives of Surgery 2024; 409(1) doi: 10.1007/s00423-024-03249-4
|
| 17 |
Mina S. Makary, Umang Khandpur, Jordan M. Cloyd, Khalid Mumtaz, Joshua D. Dowell. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies. Cancers 2020; 12(7): 1914 doi: 10.3390/cancers12071914
|
| 18 |
Shun-Chao Yang, Lei Liang, Ming-Da Wang, Xian-Ming Wang, Li-Hui Gu, Kong-Ying Lin, Ya-Hao Zhou, Ting-Hao Chen, Wei-Min Gu, Jie Li, Hong Wang, Zhong Chen, Chao Li, Lan-Qing Yao, Yong-Kang Diao, Li-Yang Sun, Cheng-Wu Zhang, Yong-Yi Zeng, Wan Yee Lau, Dong-Sheng Huang, Feng Shen, Tian Yang. Prospective validation of the Eastern Staging in predicting survival after surgical resection for patients with hepatocellular carcinoma: a multicenter study from China. HPB 2023; 25(1): 81 doi: 10.1016/j.hpb.2022.09.002
|
| 19 |
Lei Xu, Lin Chen, Wei Zhang. Neoadjuvant treatment strategies for hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2021; 13(12): 1550-1566 doi: 10.4240/wjgs.v13.i12.1550
|
| 20 |
Zhifeng Lin, Xiaohui Ji, Nana Tian, Yu Gan, Li Ke. APOB is a potential prognostic biomarker in hepatocellular carcinoma. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-00877-6
|
| 21 |
Francesca Matilde Schipilliti, Ingrid Garajová, Giulia Rovesti, Rita Balsano, Federico Piacentini, Massimo Dominici, Fabio Gelsomino. The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review. Pharmaceuticals 2021; 14(1): 43 doi: 10.3390/ph14010043
|
| 22 |
Lingling Guo, Cuntao Hu, Mengwen Yao, Guang Han. Mechanism of sorafenib resistance associated with ferroptosis in HCC. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1207496
|
| 23 |
Yusra Zarlashat, Shakil Abbas, Abdul Ghaffar. Hepatocellular Carcinoma: Beyond the Border of Advanced Stage Therapy. Cancers 2024; 16(11): 2034 doi: 10.3390/cancers16112034
|
| 24 |
Jin Hong Lim, Keunwan Park, Kyung Hwa Choi, Chan Wung Kim, Jae Ha Lee, Raymond Weicker, Cheol-Ho Pan, Seok-Mo Kim, Ki Cheong Park. Drug Discovery Using Evolutionary Similarities in Chemical Binding to Inhibit Patient-Derived Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022; 23(14): 7971 doi: 10.3390/ijms23147971
|
| 25 |
Changying Shi, Yong Li, Li Geng, Weifeng Shen, Chengjun Sui, Binghua Dai, Jiongjiong Lu, Mianshun Pan, Jiamei Yang. Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: A randomised controlled trial. European Journal of Cancer 2022; 166: 176 doi: 10.1016/j.ejca.2022.02.012
|
| 26 |
Alessandro Fancellu, Valeria Sanna, Fabrizio Scognamillo, Claudio F Feo, Gianpaolo Vidili, Giuseppe Nigri, Alberto Porcu. Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations. World Journal of Clinical Cases 2021; 9(15): 3517-3530 doi: 10.12998/wjcc.v9.i15.3517
|
| 27 |
Clarisse Brossard, Manuel Vlach, Elise Vène, Catherine Ribault, Vincent Dorcet, Nicolas Noiret, Pascal Loyer, Nicolas Lepareur, Sandrine Cammas-Marion. Synthesis of Poly(Malic Acid) Derivatives End-Functionalized with Peptides and Preparation of Biocompatible Nanoparticles to Target Hepatoma Cells. Nanomaterials 2021; 11(4): 958 doi: 10.3390/nano11040958
|
| 28 |
Maria Tampaki, George Vasileios Papatheodoridis, Evangelos Cholongitas. Intrahepatic recurrence of hepatocellular carcinoma after resection: an update. Clinical Journal of Gastroenterology 2021; 14(3): 699 doi: 10.1007/s12328-021-01394-7
|
| 29 |
Ashraf Omar, Ahmed Kaseb, Tamer Elbaz, Mohamed El-Kassas, Amr El Fouly, Abdel Fatah Hanno, Ahmed El Dorry, Ahmed Hosni, Amr Helmy, Amr S Saad, Ashwaq Alolayan, Basem Eysa, Emad Hamada, Hamdy Azim, Hany Khattab, Hesham Elghazaly, Hesham Tawfik, Hisham Ayoub, Hussein Khaled, Ibtessam Saadeldin, Imam Waked, Eman Barakat, Mahmoud El Meteini, Mohamed Hamed Shaaban, Mohamed EzzElarab, Mohamed Fathy, Mohamed Shaker, Mohamed Sobhi, Mohamed Shaker, Mohamed ElGharib, Mohammed Abdullah, Mohesn Mokhtar, Mostafa Elshazli, Omar Heikal, Osama Hetta, Reda ElWakil, Sameh Abdel Wahab, Samir Eid, Yousri Rostom. Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1547 doi: 10.2147/JHC.S404424
|
| 30 |
Kexin Wang, Xiangmin Ye, Chuanhui Yin, Qing Ren, Yupeng Chen, Xuemei Qin, Chuanzhi Duan, Aiping Lu, Li Gao, Daogang Guan. Computational Metabolomics Reveals the Potential Mechanism of Matrine Mediated Metabolic Network Against Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.859236
|
| 31 |
Nicole M. Nevarez, Gloria Y. Chang, Adam C. Yopp. An Overview of Clinical Trials in the Treatment of Resectable Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 2023; 32(1): 101 doi: 10.1016/j.soc.2022.07.008
|
| 32 |
Chao Huang, Peijun Hu, Yu Tian, Yiwei Gao, Yangyang Wang, Qi Zhang, Tingbo Liang, Jingsong Li. Mining Whole-liver Information with Deep Learning for Preoperatively Predicting HCC Recurrence-free Survival *. 2023 45th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2023; : 1 doi: 10.1109/EMBC40787.2023.10340426
|
| 33 |
Davide Ippolito, Cesare Maino, Marco Gatti, Paolo Marra, Riccardo Faletti, Francesco Cortese, Riccardo Inchingolo, Sandro Sironi. Radiological findings in non-surgical recurrent hepatocellular carcinoma: From locoregional treatments to immunotherapy. World Journal of Gastroenterology 2023; 29(11): 1669-1684 doi: 10.3748/wjg.v29.i11.1669
|
| 34 |
Lan-Qing Yao, Zheng-Liang Chen, Zi-Han Feng, Yong-Kang Diao, Chao Li, Hai-Ying Sun, Jian-Hong Zhong, Ting-Hao Chen, Wei-Min Gu, Ya-Hao Zhou, Wan-Guang Zhang, Hong Wang, Yong-Yi Zeng, Han Wu, Ming-Da Wang, Xin-Fei Xu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang. Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis. Annals of Surgical Oncology 2022; 29(7): 4291 doi: 10.1245/s10434-022-11454-y
|
| 35 |
Lisa S. Parks, Patricia Little. Cirrhosis, Hepatocellular Carcinoma, and Locoregional Therapies. Journal of Radiology Nursing 2022; 41(2): 129 doi: 10.1016/j.jradnu.2022.01.005
|
| 36 |
Ahmed Montasser, Aurélie Beaufrère, François Cauchy, Mohamed Bouattour, Olivier Soubrane, Miguel Albuquerque, Valérie Paradis. Transarterial chemoembolisation enhances programmed death‐1 and programmed death‐ligand 1 expression in hepatocellular carcinoma. Histopathology 2021; 79(1): 36 doi: 10.1111/his.14317
|
| 37 |
Zhenchang Wang, Yunjie Duan, Jinmei Zhang, Yanhang Lv, Shanshan Wu, Mingrong Cheng, Akshaya Srikanth Bhagavathula, Wafa Ali Aldhaleei, Cain Clark, Zongwei Huo. Preoperative antiviral therapy and microvascular invasion in hepatitis B virus-related hepatocellular carcinoma: A meta-analysis. European Journal of Pharmacology 2020; 883: 173382 doi: 10.1016/j.ejphar.2020.173382
|
| 38 |
Wanjing Zheng, Xiaodan Chen, Meilian Xiong, Yu Zhang, Yang Song, Dairong Cao. Clinical‐Radiologic Morphology‐Radiomics Model on Gadobenate Dimeglumine‐Enhanced MRI for Identification of Highly Aggressive Hepatocellular Carcinoma: Temporal Validation and Multiscanner Validation. Journal of Magnetic Resonance Imaging 2024; 60(6): 2643 doi: 10.1002/jmri.29293
|
| 39 |
Changying Shi, Yong Li, Li Geng, Weifeng Shen, Chengjun Sui, Binghua Dai, Jiongjiong Lu, Mianshun Pan, Jiamei Yang. Adjuvant Stereotactic Body Radiotherapy After Marginal Resection for Hepatocellular Carcinoma With Micro-Vascular Invasion: A Randomized Controlled Trial. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3912534
|
| 40 |
Zong‐Han Liu, Zong‐Tao Chai, Jin‐Kai Feng, Yu‐Chao Hou, Xiu‐Ping Zhang, Zhen‐Hua Chen, Yan‐Jun Xiang, Wei‐Xing Guo, Jie Shi, Shu‐Qun Cheng. A reasonable identification of the early recurrence time based on microvascular invasion for hepatocellular carcinoma after R0 resection: A multicenter retrospective study. Cancer Medicine 2023; 12(9): 10294 doi: 10.1002/cam4.5758
|
| 41 |
Lei Gong, Wenzhen Wang, Fei Yu, Zenghua Deng, Nan Luo, Xinjing Zhang, Jianfen Chen, Jirun Peng. Caffeic acid phenethyl ester derivative exerts remarkable anti-hepatocellular carcinoma effect, non-inferior to sorafenib, in vivo analysis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-65496-1
|
| 42 |
Chiun Hsu, Lorenza Rimassa, Hui-Chuan Sun, Arndt Vogel, Ahmed O. Kaseb. Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab. Therapeutic Advances in Medical Oncology 2021; 13 doi: 10.1177/17588359211031141
|
| 43 |
Jeng-Shiun Du, Shih-Hsien Hsu, Shen-Nien Wang. The Current and Prospective Adjuvant Therapies for Hepatocellular Carcinoma. Cancers 2024; 16(7): 1422 doi: 10.3390/cancers16071422
|
| 44 |
Bin Yu, Han Liang, Qifa Ye, Yanfeng Wang. Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 Resection. Journal of Gastrointestinal Surgery 2021; 25(1): 112 doi: 10.1007/s11605-020-04554-1
|
| 45 |
S. V. Gautier, A. R. Monakhov, O. M. Tsirulnikova, S. I. Zubenko, E. V. Sitnikova, D. V. Umrik, K. A. Nosov, N. D. Kurtak. Outcomes of liver transplantation in hepatocellular carcinoma: a single-center experience. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2): 67 doi: 10.16931/1995-5464.2020267-76
|
| 46 |
Andreas Koulouris, Christos Tsagkaris, Vasiliki Spyrou, Eleni Pappa, Aikaterini Troullinou, Michail Nikolaou. Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options. Journal of Hepatocellular Carcinoma 2021; : 387 doi: 10.2147/JHC.S300182
|
| 47 |
Jie Jian, Yuan Nie, Chenkai Huang, Sizhe Wan, Xuan Zhu. A scoring model predicting overall survival for hepatocellular carcinoma patients who receive surgery and chemotherapy. Indian Journal of Surgery 2022; 84(S2): 365 doi: 10.1007/s12262-021-03224-z
|
| 48 |
Seok-Mo Kim, Keunwan Park, Jin Hong Lim, Hyeok Jun Yun, Sang Yong Kim, Kyung Hwa Choi, Chan Wung Kim, Jae Ha Lee, Raymond Weicker, Cheol-Ho Pan, Ki Cheong Park. Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid Carcinoma. International Journal of Molecular Sciences 2022; 23(18): 10378 doi: 10.3390/ijms231810378
|
| 49 |
Cheng Ma, Yin Cao, Guang Zhang, Jiannan Qiu, Yan Zhou, Peng Wang, Shuo Wang, Dongliang Yan, Ding Ma, Chunping Jiang, Zhongxia Wang. Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy. Journal of Hepatocellular Carcinoma 2023; : 217 doi: 10.2147/JHC.S391755
|
| 50 |
Stepan M. Esagian, Christos D. Kakos, Emmanouil Giorgakis, Lyle Burdine, J. Camilo Barreto, Michail N. Mavros. Adjuvant Transarterial Chemoembolization Following Curative-Intent Hepatectomy Versus Hepatectomy Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cancers 2021; 13(12): 2984 doi: 10.3390/cancers13122984
|
| 51 |
Yi-Li Chen, Ching-Chuan Hsieh, Pei-Ming Chu, Jing-Yi Chen, Yu-Chun Huang, Cheng-Yi Chen. Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review). Oncology Reports 2023; 49(3) doi: 10.3892/or.2023.8485
|
| 52 |
Amblessed E. Onuma, Hongji Zhang, Hai Huang, Terence M. Williams, Anne Noonan, Allan Tsung. Immune Checkpoint Inhibitors in Hepatocellular Cancer: Current Understanding on Mechanisms of Resistance and Biomarkers of Response to Treatment. Gene Expression 2020; 20(1): 53 doi: 10.3727/105221620X15880179864121
|
| 53 |
Dominik T. Koch, Haochen Yu, Iris Beirith, Malte Schirren, Moritz Drefs, Yunfei Liu, Mathilda Knoblauch, Dionysios Koliogiannis, Weiwei Sheng, Enrico N. De Toni, Alexandr V. Bazhin, Bernhard W. Renz, Markus O. Guba, Jens Werner, Matthias Ilmer. Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04615-4
|
| 54 |
Christopher D. Griffiths, Betty Zhang, Kasia Tywonek, Brandon M. Meyers, Pablo E. Serrano. Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma. JAMA Network Open 2022; 5(7): e2222721 doi: 10.1001/jamanetworkopen.2022.22721
|
| 55 |
Liuhua Long, Bo Chen, Hongzhi Wang, Yuting Zhao, Fan Wu, Liming Wang, Weiqi Rong, Jianxiong Wu, Yexiong Li, Weihu Wang. Survival benefit of radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis based on phase II study. Radiotherapy and Oncology 2023; 180: 109462 doi: 10.1016/j.radonc.2022.109462
|
| 56 |
Stefanie J. Hectors, Sara Lewis, Cecilia Besa, Michael J. King, Daniela Said, Juan Putra, Stephen Ward, Takaaki Higashi, Swan Thung, Shen Yao, Ilaria Laface, Myron Schwartz, Sacha Gnjatic, Miriam Merad, Yujin Hoshida, Bachir Taouli. MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma. European Radiology 2020; 30(7): 3759 doi: 10.1007/s00330-020-06675-2
|
| 57 |
Kevin P. Labadie, Jonathan G. Sham. Adjuvant Transcatheter Arterial Infusion Therapy for Hepatocellular Carcinoma: Not Yet for Everybody. Annals of Surgical Oncology 2020; 27(11): 4070 doi: 10.1245/s10434-020-08702-4
|
| 58 |
Hara Afaloniati, Katerina Angelopoulou, Alexander Giakoustidis, Alexandros Hardas, Athanasios Pseftogas, Kali Makedou, Athanasios Gargavanis, Thomas Goulopoulos, Stavros Iliadis, Vasileios Papadopoulos, Apostolos Papalois, George Mosialos, Theofilos Poutahidis, Dimitrios Giakoustidis. <p>HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice</p>. OncoTargets and Therapy 2020; : 5575 doi: 10.2147/OTT.S250233
|
| 59 |
Clifford Akateh, Aslam M Ejaz, Timothy Michael Pawlik, Jordan M Cloyd. Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma. World Journal of Hepatology 2020; 12(10): 693-708 doi: 10.4254/wjh.v12.i10.693
|
| 60 |
Yao-chang Luo, Hai-lin Lu, Wen-ling Song, Fei-fei Xuan. Multidisciplinary treatment of advanced hepatocellular carcinoma with severe arterioportal shunt: a case report. Journal of International Medical Research 2021; 49(7) doi: 10.1177/03000605211024840
|
| 61 |
Ying Liu, Yuzhu Wang, Xinkun Guo, Yifeng He, Jian Zhou, Qianzhou Lv, Xiaowu Huang, Xiaoyu Li. Comparative Effectiveness of Adjuvant Treatment for Resected Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.709278
|
| 62 |
Hu Chen, Minglei Teng, Hongrui Zhang, Xiaoliu Liang, Hongwei Cheng, Gang Liu. Advanced radionuclides in diagnosis and therapy for hepatocellular carcinoma. Chinese Chemical Letters 2022; 33(7): 3371 doi: 10.1016/j.cclet.2022.03.079
|
| 63 |
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi. Systemic Adjuvant Treatment in Hepatocellular Carcinoma: Tempted to do Something Rather than Nothing. Future Oncology 2020; 16(32): 2587 doi: 10.2217/fon-2020-0669
|
| 64 |
Bi Peng, Yuanliang Yan, Zhijie Xu. The bioinformatics and experimental analysis of AlkB family for prognosis and immune cell infiltration in hepatocellular carcinoma. PeerJ 2021; 9: e12123 doi: 10.7717/peerj.12123
|
| 65 |
Mark A. Healy, Michael A. Choti. Hepatocellular Carcinoma Recurrence Risk in the Context of Emerging Therapies. Annals of Surgical Oncology 2022; 29(7): 4030 doi: 10.1245/s10434-022-11709-8
|
| 66 |
Qi Huo, Junjie Hu, Binfen Hou, Mei Zhao, Xue Han, Yulin Du, Yao Li. Clinicopathological Features and Prognostic Evaluation of UBR5 in Liver Cancer Patients. Pathology and Oncology Research 2022; 28 doi: 10.3389/pore.2022.1610396
|
| 67 |
Yutaka Endo, Henrique A. Lima, Laura Alaimo, Zorays Moazzam, Zachary Brown, Chanza F. Shaikh, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Feng Shen, Itaru Endo, Timothy M. Pawlik. Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinoma. HPB 2023; 25(3): 353 doi: 10.1016/j.hpb.2022.12.009
|
| 68 |
Wei-Yue Chen, Chao Li, Zhi-Peng Liu, Qing-Yu Kong, Li-Yang Sun, Yong-Yi Zeng, Ying-Jian Liang, Ya-Hao Zhou, Ting-Hao Chen, Zi-Xiang Chen, Ming-Da Wang, Lan-Qing Yao, Wan Yee Lau, Timothy M Pawlik, Feng Shen, Jian-Song Ji, Tian Yang. Novel online calculator to predict reduced risk of early recurrence from adjuvant transarterial chemoembolisation for patients with hepatocellular carcinoma. eGastroenterology 2023; 1(1): e100008 doi: 10.1136/egastro-2023-100008
|
| 69 |
Hury Viridiana Hernández-Galdámez, Samia Fattel-Fazenda, Teresita N. J. Flores-Téllez, Mario Alejandro Aguilar-Chaparro, Jonathan Mendoza-García, Lidia C. Díaz-Fernández, Eunice Romo-Medina, Yesennia Sánchez-Pérez, Jaime Arellanes-Robledo, Mireya De la Garza, Saúl Villa-Treviño, Carolina Piña-Vázquez. Iron-saturated bovine lactoferrin: a promising chemopreventive agent for hepatocellular carcinoma. Food & Function 2024; 15(8): 4586 doi: 10.1039/D3FO05184F
|
| 70 |
Ting Yang, Hong Wei, Yuanan Wu, Yun Qin, Jie Chen, Hanyu Jiang, Bin Song. Predicting histologic differentiation of solitary hepatocellular carcinoma up to 5 cm on gadoxetate disodium-enhanced MRI. Insights into Imaging 2023; 14(1) doi: 10.1186/s13244-022-01354-w
|
| 71 |
Yu-Xue Gao, Qi-Qi Ning, Peng-Xiang Yang, Yuan-Yue Guan, Peng-Xiang Liu, Meng-Lu Liu, Lu-Xin Qiao, Xiang-Hua Guo, Tong-Wang Yang, De-Xi Chen. Recent advances in recurrent hepatocellular carcinoma therapy. World Journal of Hepatology 2023; 15(4): 460-476 doi: 10.4254/wjh.v15.i4.460
|
| 72 |
Elise Vène, Kathleen Jarnouen, Catherine Ribault, Manuel Vlach, Yann Verres, Mickaël Bourgeois, Nicolas Lepareur, Sandrine Cammas-Marion, Pascal Loyer. Circumsporozoite Protein of Plasmodium berghei- and George Baker Virus A-Derived Peptides Trigger Efficient Cell Internalization of Bioconjugates and Functionalized Poly(ethylene glycol)-b-poly(benzyl malate)-Based Nanoparticles in Human Hepatoma Cells. Pharmaceutics 2022; 14(4): 804 doi: 10.3390/pharmaceutics14040804
|
| 73 |
_ _, Oszkár Hahn, Attila Szijártó, Damján Pekli, András Fülöp, Bálint Kokas, Dávid Bárdos, Csilla András, Péter Bartek, István Battyáni, János Bezsilla, György Bodoky, Attila Bursics, Magdolna Dank, Zsófia Dankovics, Ákos Deák Pál, Kristóf Dede, Gyula Demeter, Attila Doros, Ibolyka Dudás, Zsófia Egyed, Róbert Farkas, Zsuzsanna Gerlei, Tamás Györke, Krisztina Hagymási, Oszkár Hahn, Erika Hitre, József Hőhn, Viktor Jancsik, Zsolt Káposztás, István Király, András Kiss, László Kóbori, Péter Kupcsulik, Gábor Lakatos, István Lázár, Tamás Lóderer, Endre Nagy, Attila Oláh, Péter Pajor, András Papp, Gabriella Pár, Mihály Patyánik, Damján Pekli, Ágota Petrányi, András Petri, László Piros, János Schuller, László Sikorszki, József Szabó, Eszter Székely, Attila Szijártó, Andrea Szombati, László Torday, Judit Tóth, Lajos Barna Tóth, Edit Dósa, László Harsányi, Zsolt Horváth, Gábor István, László Landherr, György Lázár, Gabriella Lengyel, József Lővey, László Mangel, Pál Maurovich Horváth, Balázs Nemes, András Palkó, Zsuzsa Schaff, Ferenc Szalay, Ákos Szűcs, András Vereczkei. A hepatocellularis carcinoma komplex kezelése.. Orvosi Hetilap 2022; 162(Supplement-2): 2 doi: 10.1556/650.2021.32431
|
| 74 |
Chien Peter Chen. Role of External Beam Radiotherapy in Hepatocellular Carcinoma. Clinics in Liver Disease 2020; 24(4): 701 doi: 10.1016/j.cld.2020.07.006
|
| 75 |
John R. Bergquist, Amy Y. Li, Christopher S. Javadi, Byrne Lee, Jeffrey A. Norton, George A. Poultsides, Monica M. Dua, Brendan C. Visser. Regional lymph node sampling in hepatoma resection: insight into prognosis. HPB 2021; 23(9): 1360 doi: 10.1016/j.hpb.2021.01.006
|
| 76 |
Ludovico Abenavoli, Michele Montori, Gianluca Svegliati Baroni, Maria Eva Argenziano, Francesca Giorgi, Giuseppe Guido Maria Scarlata, Francesca Ponziani, Emidio Scarpellini. Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors. Medicina 2023; 59(8): 1427 doi: 10.3390/medicina59081427
|
| 77 |
Yutaka Endo, Zorays Moazzam, Laura Alaimo, Selamawit Woldesenbet, Henrique A. Lima, Muhammad M. Munir, Erryk Katayama, Jason Yang, Lovette Azap, Chanza F. Shaikh, Francesca Ratti, Hugo P. Marques, François Cauchy, Vincent Lam, George A. Poultsides, Minoru Kitago, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Alfredo Guglielmi, Ana Gleisner, Tom Hugh, Luca Aldrighetti, Feng Shen, Itaru Endo, Timothy M. Pawlik. Modified integrated tumor burden, liver function, systemic inflammation, and tumor biology score to predict long-term outcomes after resection for hepatocellular carcinoma. HPB 2023; 25(12): 1484 doi: 10.1016/j.hpb.2023.07.901
|
| 78 |
Liang Li, Huiwen Qiu. Asperulosidic Acid Restrains Hepatocellular Carcinoma Development and Enhances Chemosensitivity Through Inactivating the MEKK1/NF-κB Pathway. Applied Biochemistry and Biotechnology 2024; 196(1): 1 doi: 10.1007/s12010-023-04500-2
|
| 79 |
Zhifeng Lin, Xuqiong Huang, Xiaohui Ji, Nana Tian, Yu Gan, Li Ke. Analysis of multiple databases identifies crucial genes correlated with prognosis of hepatocellular carcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13159-4
|
| 80 |
In-Jung Kim, Sung Hwan Yoo, Jung Il Lee, Kwan Sik Lee, Hyun Woong Lee, Jin Hong Lim. Long-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case report. Journal of Liver Cancer 2022; 22(1): 84 doi: 10.17998/jlc.2022.03.07
|
| 81 |
Hai-Tao Zhao, Jian-Qiang Cai. Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma. World Journal of Gastroenterology 2021; 27(47): 8069-8080 doi: 10.3748/wjg.v27.i47.8069
|
| 82 |
Hiroji Shinkawa, Shogo Tanaka, Shigekazu Takemura, Ryosuke Amano, Kenjiro Kimura, Masahiko Kinoshita, Kanae Takahashi, Shuichiro Matsuzaki, Shoji Kubo. Nomograms predicting extra- and early intrahepatic recurrence after hepatic resection of hepatocellular carcinoma. Surgery 2021; 169(4): 922 doi: 10.1016/j.surg.2020.10.012
|
| 83 |
Yafei Wang, Biao Gao, Tianyu Jiao, Wenwen Zhang, Huizhong Shi, Hao Jiang, Xuerui Li, Junfeng Li, Xinlan Ge, Ke Pan, Chonghui Li, Guankun Mao, Shichun Lu. CCL5/CCR5/CYP1A1 pathway prompts liver cancer cells to survive in the combination of targeted and immunological therapies. Cancer Science 2024; 115(11): 3552 doi: 10.1111/cas.16320
|
| 84 |
Min Wang, Shan Huang, Zefeng Chen, Zhiwei Han, Kezhi Li, Chuang Chen, Guobin Wu, Yinnong Zhao. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07625-3
|
| 85 |
Zachary Whitham, David Hsiehchen. Role of Neoadjuvant Therapy Prior to Curative Resection in Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 2024; 33(1): 87 doi: 10.1016/j.soc.2023.07.003
|
| 86 |
Zhi-Xi Li, Qi-Fan Zhang, Jia-Ming Huang, Shao-Jian Huang, Han-Biao Liang, Hao Chen, Zhan-Hong Lai, Qing-Yan Li, Jian-Ping Qian, Kai Wang, Jie Zhou. Safety and efficacy of postoperative adjuvant therapy with atezolizumab and bevacizumab after radical resection of hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2023; 47(7): 102165 doi: 10.1016/j.clinre.2023.102165
|
| 87 |
Zeyu Wang, Ningning Zhang, Jiayu Lv, Cuihua Ma, Jie Gu, Yawei Du, Yibo Qiu, Zhiguang Zhang, Man Li, Yong Jiang, Jianqiu Zhao, Huiqin Du, Zhiwei Zhang, Wei Lu, Yan Zhang, Luca Miele. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/4037639
|
| 88 |
Xian Lu, Jialei Mao, Yaodong Wang, Yonggang Huang, Maolin Gu. Water extract of frankincense and myrrh inhibits liver cancer progression and epithelial‑mesenchymal transition through Wnt/β‑catenin signaling. Molecular and Clinical Oncology 2023; 19(4) doi: 10.3892/mco.2023.2673
|
| 89 |
Hang-Seok Chang, Yonjung Kim, So Young Lee, Hyeok Jun Yun, Ho-Jin Chang, Ki Cheong Park. Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma. International Journal of Molecular Sciences 2023; 24(8): 7069 doi: 10.3390/ijms24087069
|
| 90 |
Ming-Da Wang, Hao Xiang, Ling Zhang, Chao Wang. Integration of OV6 expression and CD68+ tumor-associated macrophages with clinical features better predicts the prognosis of patients with hepatocellular carcinoma. Translational Oncology 2022; 25: 101509 doi: 10.1016/j.tranon.2022.101509
|
| 91 |
Xiaoshi Zhang, Xiaodong Zhu, Jianhong Zhong, Yang Zhao, Xiaoyun Zhang, Wenwen Zhang, Feng Ye, Chaoxu Yang, Jun Xue, Rui Xiong, Jiabei Wang, Shunli Shen, Yangxun Pan, Dongxiao Li, Tianqiang Song, Xinyu Bi, Huichuan Sun, Bangde Xiang, Shanzhi Gu, Tianfu Wen, Shichun Lu, Yongjun Chen, Tao Yin, Lianxin Liu, Ming Kuang, Li Xu, Deyu Li, Jianqiang Cai. Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-60379-x
|
| 92 |
Yanzhi Wan, Keqin Tan, Hong Zhu. QL1604 combined with bevacizumab as an innovative first-line treatment for HCC patient with extensive metastasis who showed remarkable effect: a case report. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1364871
|
| 93 |
Suchira Gallage, María García-Beccaria, Marta Szydlowska, Mohammad Rahbari, Raphael Mohr, Frank Tacke, Mathias Heikenwalder. The therapeutic landscape of hepatocellular carcinoma. Med 2021; 2(5): 505 doi: 10.1016/j.medj.2021.03.002
|
| 94 |
Tao Wei, Xu-Feng Zhang, Feng Xue, Fabio Bagante, Francesca Ratti, Hugo P. Marques, Silvia Silva, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Razvan Grigorie, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Multi-Institutional Development and External Validation of a Nomogram for Prediction of Extrahepatic Recurrence After Curative-Intent Resection for Hepatocellular Carcinoma. Annals of Surgical Oncology 2021; 28(12): 7624 doi: 10.1245/s10434-021-10142-7
|
| 95 |
H. Lang, S. Heinrich, F. Bartsch, F. Hüttl, J. Baumgart, J. Mittler. Chirurgische Therapie bei Lebertumoren – Leberresektion und -transplantation. Der Internist 2020; 61(2): 147 doi: 10.1007/s00108-020-00754-8
|
| 96 |
Seo Yeon Youn, Bohyun Kim, Dong Hwan Kim, Ho Joong Choi, Pil Soo Sung, Joon-Il Choi. Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy–treated hepatocellular carcinoma. European Radiology 2022; 32(9): 6270 doi: 10.1007/s00330-022-08720-8
|
| 97 |
Qimeng Wang, Jin Huang, Huihua Zhang, Huan Liu, Min Yu. Identification and analysis of immune-related subtypes of hepatocellular carcinoma. Experimental Biology and Medicine 2021; 246(6): 667 doi: 10.1177/1535370220970130
|
| 98 |
Claudia A. M. Fulgenzi, Thomas Talbot, Sam M. Murray, Marianna Silletta, Bruno Vincenzi, Alessio Cortellini, David J. Pinato. Immunotherapy in Hepatocellular Carcinoma. Current Treatment Options in Oncology 2021; 22(10) doi: 10.1007/s11864-021-00886-5
|
| 99 |
Congjian Shi, Hongqin Yang, Zhenghong Zhang. Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver Diseases. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00139
|
| 100 |
|
| 101 |
Fuli Xin, Ming Wu, Zhixiong Cai, Xiaolong Zhang, Zuwu Wei, Xiaolong Liu, Jingfeng Liu. Tumor Microenvironment Triggered Cascade‐Activation Nanoplatform for Synergistic and Precise Treatment of Hepatocellular Carcinoma. Advanced Healthcare Materials 2021; 10(10) doi: 10.1002/adhm.202002036
|
| 102 |
Atsushi Oyama, Kazuhiro Nouso, Kenichi Yoshimura, Yuki Morimoto, Shinichiro Nakamura, Hideki Onishi, Akinobu Takaki, Shouta Iwadou, Kazuya Kariyama, Kenji Kuwaki, Kazuhisa Yabushita, Kosaku Sakaguchi, Jyunichi Toshimori, Haruhiko Kobashi, Akio Moriya, Masaharu Ando, Hiroyuki Okada. Randomized controlled study to examine the efficacy of hepatic arterial infusion chemotherapy with cisplatin before radiofrequency ablation for hepatocellular carcinoma. Hepatology Research 2021; 51(6): 694 doi: 10.1111/hepr.13633
|
| 103 |
Xiao-Xue Gou, Hong-Yun Shi, Chao Li, Zheng-Liang Chen, Wei Ouyang, Li-Yang Sun, Yong-Kang Diao, Ming-Da Wang, Lan-Qing Yao, Li-Hui Gu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Jun Xue, Tian Yang. Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study. International Journal of Radiation Oncology*Biology*Physics 2022; 114(2): 238 doi: 10.1016/j.ijrobp.2022.05.020
|
| 104 |
凌 于. Research Progress of Medical Imaging Predictions of HCC Recurrence after Treatment. Advances in Clinical Medicine 2024; 14(10): 632 doi: 10.12677/acm.2024.14102706
|
| 105 |
Giovanni Galati, Antonio Fabio Massimo Vainieri, Claudia Angela Maria Fulgenzi, Stefano Di Donato, Marianna Silletta, Paolo Gallo, Angelo Onorato, Umberto Vespasiani-Gentilucci, Antonio Picardi. Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis. Current Drug Metabolism 2020; 21(11): 866 doi: 10.2174/1389200221999200918141239
|